Miller Huang, Ph.D. - Publications

Affiliations: 
2011 Molecular Pathology University of California, San Diego, La Jolla, CA 
Area:
Pathology, Molecular Biology, Oncology, Cell Biology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Cheng B, Fang W, Pastor S, March AR, Porras T, Wu HW, Velez M, Parekh C, Maris JM, Asgharzadeh S, Huang M. Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumors. Scientific Reports. 14: 23050. PMID 39367051 DOI: 10.1038/s41598-024-73947-y  0.479
2024 Saldana-Guerrero IM, Montano-Gutierrez LF, Boswell K, Hafemeister C, Poon E, Shaw LE, Stavish D, Lea RA, Wernig-Zorc S, Bozsaky E, Fetahu IS, Zoescher P, Pötschger U, Bernkopf M, Wenninger-Weinzierl A, ... ... Huang M, et al. A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations. Nature Communications. 15: 3745. PMID 38702304 DOI: 10.1038/s41467-024-47945-7  0.639
2024 Huang M, Fang W, Farrel A, Li L, Chronopoulos A, Nasholm N, Cheng B, Zheng T, Yoda H, Barata MJ, Porras T, Miller ML, Zhen Q, Ghiglieri L, McHenry L, et al. ALK upregulates POSTN and WNT signaling to drive neuroblastoma. Cell Reports. 43: 113927. PMID 38451815 DOI: 10.1016/j.celrep.2024.113927  0.734
2022 Kuzuoglu-Ozturk D, Aksoy O, Schmidt C, Lea R, Larson JD, Phelps RRL, Nasholm N, Holt M, Contreras A, Huang M, Wong-Michalak S, Shao H, Wechsler-Reya R, Phillips JJ, Gestwicki JE, et al. N-myc mediated translation control is a therapeutic vulnerability in medulloblastoma. Cancer Research. PMID 36264168 DOI: 10.1158/0008-5472.CAN-22-0945  0.475
2022 Becklin KL, Draper GM, Madden RA, Kluesner MG, Koga T, Huang M, Weiss WA, Spector LG, Largaespada DA, Moriarity BS, Webber BR. Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies. The Crispr Journal. 5: 517-535. PMID 35972367 DOI: 10.1089/crispr.2022.0032  0.565
2019 Huang M, Tailor J, Zhen Q, Gillmor AH, Miller ML, Weishaupt H, Chen J, Zheng T, Nash EK, McHenry LK, An Z, Ye F, Takashima Y, Clarke J, Ayetey H, et al. Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis. Cell Stem Cell. PMID 31204176 DOI: 10.1016/J.Stem.2019.05.013  0.735
2019 Tailor J, Huang M, Smith A, Weiss WA. Recapitulation of Genetic Predisposition to Medulloblastoma in Human Neuroepithelial Stem Cells Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_216  0.697
2018 Tailor J, Huang M, Smith A, Weiss W. A human iPS cell-based model of medulloblastoma demonstrates co-operativity between SHH signalling and mutation in an epigenetic modifier Neuro-Oncology. 20: i2-i3. DOI: 10.1093/neuonc/nox237.009  0.516
2017 Huang M, Tailor JK, Zhen Q, Nash EK, Phillips J, Morrissy S, Kool M, Pfister SM, Swartling FJ, Taylor MD, Smith A, Weiss WA. TMOD-11. HUMAN STEM CELL BASED MODEL OF MEDULLOBLASTOMA Neuro-Oncology. 19: vi256-vi257. DOI: 10.1093/Neuonc/Nox168.1050  0.749
2017 Huang M, Zheng T, Guo J, Sperring C, Miller M, McHenry L, Zhen Q, Moriarity B, Bronner M, Conklin B, Largaespada D, Maris J, Matthay K, Weiss W. TMOD-09. HUMAN PLURIPOTENT STEM CELL-BASED MODELS OF NEUROBLASTOMA Neuro-Oncology. 19: vi256-vi256. DOI: 10.1093/Neuonc/Nox168.1048  0.67
2017 Čančer M, Hutter S, Rosén G, Hellström A, Essand M, Huang M, Tailor J, Smith A, Weiss WA, Falk A, Weishaupt H, Swartling F. TMOD-05. MYCN OVEREXPRESSION AND STABILIZATION DRIVES MEDULLOBLASTOMA FROM HUMAN NEURO-EPITHELIAL STEM CELLS Neuro-Oncology. 19: vi255-vi255. DOI: 10.1093/Neuonc/Nox168.1044  0.752
2016 Huang M, Miller ML, McHenry LK, Zheng T, Zhen Q, Ilkhanizadeh S, Conklin BR, Bronner ME, Weiss WA. Generating trunk neural crest from human pluripotent stem cells. Scientific Reports. 6: 19727. PMID 26812940 DOI: 10.1038/Srep19727  0.77
2015 Huang M, McHenry LK, Miller ML, Kim GE, Moriarity BS, Miyaoka Y, Bronner ME, Largaespada DA, Conklin BR, Ji HP, Maris JM, Matthay KK, Weiss WA. Abstract 3230: Human stem cell-based model of MYCN-driven neuroblastoma Cancer Research. 75: 3230-3230. DOI: 10.1158/1538-7445.Am2015-3230  0.695
2014 Ilkanizadeh S, Lau J, Huang M, Foster DJ, Wong R, Frantz A, Wang S, Weiss WA, Persson AI. Glial progenitors as targets for transformation in glioma. Advances in Cancer Research. 121: 1-65. PMID 24889528 DOI: 10.1016/B978-0-12-800249-0.00001-9  0.767
2014 Miyaoka Y, Chan AH, Judge LM, Yoo J, Huang M, Nguyen TD, Lizarraga PP, So PL, Conklin BR. Isolation of single-base genome-edited human iPS cells without antibiotic selection. Nature Methods. 11: 291-3. PMID 24509632 DOI: 10.1038/Nmeth.2840  0.471
2013 Huang M, Weiss WA. Neuroblastoma and MYCN. Cold Spring Harbor Perspectives in Medicine. 3: a014415. PMID 24086065 DOI: 10.1101/Cshperspect.A014415  0.55
2013 Sun Y, Dong Z, Jin T, Ang KH, Huang M, Haston KM, Peng J, Zhong TP, Finkbeiner S, Weiss WA, Arkin MR, Jan LY, Guo S. Imaging-based chemical screening reveals activity-dependent neural differentiation of pluripotent stem cells. Elife. 2: e00508. PMID 24040509 DOI: 10.7554/Elife.00508  0.585
2013 Kreitzer FR, Salomonis N, Sheehan A, Huang M, Park JS, Spindler MJ, Lizarraga P, Weiss WA, So PL, Conklin BR. A robust method to derive functional neural crest cells from human pluripotent stem cells. American Journal of Stem Cells. 2: 119-31. PMID 23862100  0.63
2013 Huang M, Weiss WA. G34, another connection between MYCN and a pediatric tumor. Cancer Discovery. 3: 484-6. PMID 23658294 DOI: 10.1158/2159-8290.Cd-13-0126  0.514
2013 Sun Y, Dong Z, Jin T, Ang K, Huang M, Haston KM, Peng J, Zhong TP, Finkbeiner S, Weiss WA, Arkin MR, Jan LY, Guo S. Author response: Imaging-based chemical screening reveals activity-dependent neural differentiation of pluripotent stem cells Elife. DOI: 10.7554/Elife.00508.017  0.583
2012 Lau SK, Shields DJ, Murphy EA, Desgrosellier JS, Anand S, Huang M, Kato S, Lim ST, Weis SM, Stupack DG, Schlaepfer DD, Cheresh DA. EGFR-mediated carcinoma cell metastasis mediated by integrin αvβ5 depends on activation of c-Src and cleavage of MUC1. Plos One. 7: e36753. PMID 22586492 DOI: 10.1371/Journal.Pone.0036753  0.744
2012 Huang M, Anand S, Murphy EA, Desgrosellier JS, Stupack DG, Shattil SJ, Schlaepfer DD, Cheresh DA. EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation. Oncogene. 31: 2783-93. PMID 21963850 DOI: 10.1038/Onc.2011.450  0.57
2011 Mielgo A, Seguin L, Huang M, Camargo MF, Anand S, Franovic A, Weis SM, Advani SJ, Murphy EA, Cheresh DA. A MEK-independent role for CRAF in mitosis and tumor progression. Nature Medicine. 17: 1641-5. PMID 22081024 DOI: 10.1038/Nm.2464  0.573
2011 Shields DJ, Murphy EA, Desgrosellier JS, Mielgo A, Lau SK, Barnes LA, Lesperance J, Huang M, Schmedt C, Tarin D, Lowy AM, Cheresh DA. Oncogenic Ras/Src cooperativity in pancreatic neoplasia. Oncogene. 30: 2123-34. PMID 21242978 DOI: 10.1038/Onc.2010.589  0.725
2010 Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature Medicine. 16: 909-14. PMID 20676106 DOI: 10.1038/Nm.2186  0.454
2009 Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prévost N, Tarin D, Shattil SJ, Cheresh DA. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nature Medicine. 15: 1163-9. PMID 19734908 DOI: 10.1038/Nm.2009  0.73
2009 Ricono JM, Huang M, Barnes LA, Lau SK, Weis SM, Schlaepfer DD, Hanks SK, Cheresh DA. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. Cancer Research. 69: 1383-91. PMID 19208836 DOI: 10.1158/0008-5472.Can-08-3612  0.733
Show low-probability matches.